{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:44:37Z","timestamp":1791499477286,"version":"4.3.4"},"reference-count":49,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glucocorticoid (GC) excess drives multiple cutaneous adverse effects, including skin thinning and poor wound healing. The ubiquitously expressed enzyme 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) activates mouse corticosterone from 11-dehydrocorticosterone (and human cortisol from cortisone). We previously demonstrated elevated 11\u03b2-HSD1 activity during mouse wound healing, but the interplay between cutaneous 11\u03b2-HSD1 and systemic GC excess is unexplored. Here, we examined effects of 11\u03b2-HSD1 inhibition by carbenoxolone (CBX) in mice treated with corticosterone (CORT) or vehicle for 6 weeks. Mice were treated bidaily with topical CBX or vehicle (VEH) 7 days before wounding and during wound healing. CORT mice displayed skin thinning and impaired wound healing but also increased epidermal integrity. 11\u03b2-HSD1 activity was elevated in unwounded CORT skin and was inhibited by CBX. CORT mice treated with CBX displayed 51%, 59%, and 100% normalization of wound healing, epidermal thickness, and epidermal integrity, respectively. Gene expression studies revealed normalization of interleukin 6, keratinocyte growth factor, collagen 1, collagen 3, matrix metalloproteinase 9, and tissue inhibitor of matrix metalloproteinase 4 by CBX during wound healing. Importantly, proinflammatory cytokine expression and resolution of inflammation were unaffected by 11\u03b2-HSD1 inhibition. CBX did not regulate skin function or wound healing in the absence of CORT. Our findings demonstrate that 11\u03b2-HSD1 inhibition can limit the cutaneous effects of GC excess, which may improve the safety profile of systemic steroids and the prognosis of chronic wounds.<\/jats:p>","DOI":"10.1210\/en.2017-00607","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T18:09:10Z","timestamp":1509041350000},"page":"547-556","source":"Crossref","is-referenced-by-count":29,"title":["Topical 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice"],"prefix":"10.1210","volume":"159","author":[{"given":"Ana","family":"Tiganescu","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, England"},{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hupe","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theadora","family":"Mauro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M","family":"Holleran","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"issue":"2","key":"2020071620141647500_B1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"2020071620141647500_B2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11926-015-0513-4","article-title":"The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy","volume":"17","author":"Harris","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"2020071620141647500_B3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/acr.22574","article-title":"Glucocorticoid use in patients with systemic lupus erythematosus: association between dose and health care utilization and costs","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"2020071620141647500_B4","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaci.2015.07.046","article-title":"Acute and chronic systemic corticosteroid-related complications in patients with severe asthma","volume":"136","author":"Lefebvre","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2020071620141647500_B5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11136-014-0801-x","article-title":"A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales","volume":"24","author":"Hyland","year":"2014","journal-title":"Qual Life Res"},{"issue":"10","key":"2020071620141647500_B6","doi-asserted-by":"crossref","first-page":"e75221","DOI":"10.1371\/journal.pone.0075221","article-title":"Overtreatment of COPD with inhaled corticosteroids\u2014implications for safety and costs: cross-sectional observational study","volume":"8","author":"White","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"2020071620141647500_B7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"issue":"3","key":"2020071620141647500_B8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2020071620141647500_B9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1081-1206(10)62989-4","article-title":"Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists.","volume":"80","author":"Storms","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"2020071620141647500_B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrrheum.2015.176","article-title":"Glucocorticoids in 2015: new answers to old problems","volume":"12","author":"Jones","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2020071620141647500_B11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","article-title":"Steroidogenesis in the skin: implications for local immune functions","volume":"137","author":"Slominski","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071620141647500_B12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.steroids.2015.04.006","article-title":"On the role of skin in the regulation of local and systemic steroidogenic activities","volume":"103","author":"Slominski","year":"2015","journal-title":"Steroids"},{"issue":"1","key":"2020071620141647500_B13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/JOE-13-0420","article-title":"Increased glucocorticoid activation during mouse skin wound healing","volume":"221","author":"Tiganescu","year":"2014","journal-title":"J Endocrinol"},{"issue":"3","key":"2020071620141647500_B14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1677\/jme.1.01718","article-title":"Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1","volume":"34","author":"Bujalska","year":"2005","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2020071620141647500_B15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/jid.2010.257","article-title":"Localization, age- and site-dependent expression, and regulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in skin","volume":"131","author":"Tiganescu","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"7","key":"2020071620141647500_B16","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI64162","article-title":"11\u03b2-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects","volume":"123","author":"Tiganescu","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"2020071620141647500_B17","first-page":"S5","article-title":"History of the development of corticosteroid therapy","volume":"29","author":"Benedek","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"2020071620141647500_B18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2009.114579","article-title":"Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"69","author":"van der Goes","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"2020071620141647500_B19","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","article-title":"11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess","volume":"111","author":"Morgan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071620141647500_B20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2013.02.002","article-title":"Changing glucocorticoid action: 11\u03b2-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation","volume":"137","author":"Chapman","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2020071620141647500_B21","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1210\/en.2009-1436","article-title":"Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse","volume":"151","author":"Karatsoreos","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"2020071620141647500_B22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1523-1747.ep12482145","article-title":"Selective action of hydrocortisone on postmitotic epidermal cells in vivo","volume":"66","author":"Laurence","year":"1976","journal-title":"J Invest Dermatol"},{"issue":"3","key":"2020071620141647500_B23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.0022-202X.2005.23589.x","article-title":"Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity","volume":"124","author":"Choi","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2020071620141647500_B24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4168\/aair.2011.3.2.96","article-title":"Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids","volume":"3","author":"Kim","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"2020071620141647500_B25","doi-asserted-by":"crossref","first-page":"R1657","DOI":"10.1152\/ajpregu.00010.2006","article-title":"Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function","volume":"291","author":"Choi","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2020071620141647500_B26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2020071620141647500_B27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1523-1747.2003.12310.x","article-title":"Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption","volume":"121","author":"Denda","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"14","key":"2020071620141647500_B28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/PL00007448","article-title":"Animal models for wound repair","volume":"290","author":"Davidson","year":"1998","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"2020071620141647500_B29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jmb.2004.11.027","article-title":"From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing","volume":"345","author":"Lee","year":"2005","journal-title":"J Mol Biol"},{"issue":"1","key":"2020071620141647500_B30","doi-asserted-by":"crossref","first-page":"e29701","DOI":"10.1371\/journal.pone.0029701","article-title":"Keratinocyte-targeted overexpression of the glucocorticoid receptor delays cutaneous wound healing","volume":"7","author":"Sanchis","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"2020071620141647500_B31","doi-asserted-by":"crossref","first-page":"e25039","DOI":"10.1371\/journal.pone.0025039","article-title":"11\u03b2-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair","volume":"6","author":"Terao","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"2020071620141647500_B32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/wrr.12083","article-title":"Local blockade of glucocorticoid activation reverses stress- and glucocorticoid-induced delays in cutaneous wound h ealing","volume":"21","author":"Youm","year":"2013","journal-title":"Wound Repair Regen"},{"issue":"7","key":"2020071620141647500_B33","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1210\/en.2016-1118","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 is expressed in neutrophils and restrains an inflammatory response in male mice","volume":"157","author":"Coutinho","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"2020071620141647500_B34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2011-1398","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice","volume":"153","author":"Coutinho","year":"2012","journal-title":"Endocrinology"},{"issue":"1","key":"2020071620141647500_B35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cvr\/cvq149","article-title":"Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI","volume":"88","author":"McSweeney","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2020071620141647500_B36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"issue":"1\u20132","key":"2020071620141647500_B37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"2020071620141647500_B38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"2020071620141647500_B39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1165\/rcmb.2004-0161OC","article-title":"Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells","volume":"31","author":"Homma","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"44","key":"2020071620141647500_B40","doi-asserted-by":"crossref","first-page":"38703","DOI":"10.1074\/jbc.M111.275370","article-title":"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome","volume":"286","author":"Busillo","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"2020071620141647500_B41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/jpet.110.171975","article-title":"Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells","volume":"335","author":"Ding","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071620141647500_B42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.physbeh.2014.01.008","article-title":"The effects of social isolation on wound healing mechanisms in female mice","volume":"127","author":"Pyter","year":"2014","journal-title":"Physiol Behav"},{"issue":"4","key":"2020071620141647500_B43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/1523-1747.ep12323521","article-title":"Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing","volume":"105","author":"Brauchle","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2020071620141647500_B44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/10799900152547867","article-title":"Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice","volume":"21","author":"Gallucci","year":"2001","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"2020071620141647500_B45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2119\/molmed.2014.00130","article-title":"Activation of poly(ADP-ribose) polymerase-1 delays wound healing by regulating keratinocyte migration and production of inflammatory mediators","volume":"20","author":"El-Hamoly","year":"2014","journal-title":"Mol Med"},{"issue":"1","key":"2020071620141647500_B46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2337\/dc08-0763","article-title":"Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers","volume":"32","author":"Liu","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"2020071620141647500_B47","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jid.2016.07.018","article-title":"Epidermal mineralocorticoid receptor plays beneficial and adverse effects in skin and mediates glucocorticoid responses","volume":"136","author":"Boix","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"17","key":"2020071620141647500_B48","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1073\/pnas.0306996101","article-title":"11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics","volume":"101","author":"Sandeep","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2020071620141647500_B49","first-page":"547","article-title":"Glucocorticoid dynamics and impaired wound healing in diabetes mellitus","volume":"152","author":"Bitar","year":"1998","journal-title":"Am J Pathol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/1\/547\/23200983\/en.2017-00607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/1\/547\/23200983\/en.2017-00607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:10:01Z","timestamp":1594962601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/1\/547\/4566089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2017-00607","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,26]]}}}